Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

179.29 +0.36 (+0.20%)
Official Closing Price Updated: 7:00 PM EDT, Aug 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs
US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may not happen soon. 
Via Benzinga
Topics Economy Government World Trade
AI Stocks and Options Selling: Is It Worth the Risk?
Artificial intelligence (AI) has become one of the most exciting and volatile sectors in the stock market. As companies like (NASDAQ:NVDA), (NASDAQ:PLTR), and (NASDAQ:TSLA) drive innovation in... 
Via MarketMinute
Topics Artificial Intelligence
Cash-Secured Puts: How to Get Paid to Buy Stocks at a Discount
In a market where volatility creates both fear and opportunity, income-focused investors are increasingly turning to a lesser-known but powerful strategy: selling cash-secured puts. This options... 
Via MarketMinute
Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
From Johnson & Johnson
Via Business Wire
4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise
With solid Q2 results and 2025 guidance increases, Wall Street is upgrading these four stocks. Analysts now see palpable upside in one streaming stalwart. 
Via MarketBeat
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.
Via The Motley Fool
Topics Lawsuit Supply Chain
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US
AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and metabolic drugs. 
Via Benzinga
Topics Government
Is the Stock Market in Bubble Territory?
Via The Motley Fool
Topics Artificial Intelligence
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(NASDAQ:TEM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Apple's Online Store Is Now Live In Saudi Arabia, Flagship Stores Coming By 2026
Apple expands retail presence in Saudi Arabia by launching online store and app, offering personalized support and localized experience. 
Via Benzinga
Build Stability and Income With 3 Overlooked Dividend Leaders
Three dividend-paying stocks with high yields present an opportunity for significant passive income but a potentially high dividend payout ratio. 
Via MarketBeat
10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever
These S&P 500 dividend stocks have fallen by up to 33% and are best buys now. 
Via The Motley Fool
Topics Stocks
The Smartest Dividend Stock to Buy With $1,000 Right Now
Via The Motley Fool
Wall Street Sets New Records As Magnificent Seven Valuation Tops $18.5 Trillion: This Week In Markets
Wall Street rose to new heights during the week amid strong earnings and solid economic data. Meanwhile, Fed rate cut debate heats up. 
Via Benzinga
Topics Economy
Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie
This week's M&A news includes strategic pivots and stumbles galore, with updates from WK Kellogg, Matador Restaurant and Windsurf. 
Via Benzinga
Stock Of The Day: Breakout In Johnson & Johnson
Shares of Johnson & Johnson broke out of a classic ascending triangle pattern. They have since stalled out at resistance. 
Via Benzinga
Want Steady Income? 3 Top Dividend Stocks for July 2025
Three dividend stocks stand out in July, offering reliable income, attractive yields, and strong fundamentals to help investors navigate market volatility 
Via MarketBeat
Topics Economy Lawsuit World Trade
Johnson & Johnson Ups Forecast, Beats On EPS—But Wall Street Is Cautious
Johnson & Johnson earnings came in 3% higher than consensus. The company's operating leverage was "slightly diluted by higher tax." 
Via Benzinga
Johnson & Johnson Analysts Raise Their Forecasts After Upbeat Earnings
 
Via Benzinga
Johnson & Johnson, Intercontinental Exchange And Bitcoin ETF On CNBC's 'Final Trades'
Investors monitor shifting market dynamics and consumer behavior post-pandemic, with Sarat Sethi sticking with Johnson & Johnson amid a positive earnings report. Stephen Weiss picks iShares Bitcoin... 
Via Benzinga
Topics ETFs
Johnson & Johnson's Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income
Via The Motley Fool
Topics Bonds
Is Johnson & Johnson a Good Dividend Stock to Buy Now?
Via The Motley Fool
Johnson & Johnson Credits Tariff Delays For Strong Earnings, While Jim Cramer Pegs It On 'Lower Than Thought' Levies
Johnson & Johnson hinted at leveraging tariff delays to maintain its outlook; however, Jim Cramer credited the performance to lower tariffs. 
Via Benzinga
Topics World Trade
Market Monitor News July 17 BMO (Johnson & Johnson, Brighthouse Financial UP - GrabAGun DOWN)
Powell Panic, Pharma Power & a PEW Parade: Wall Street’s Wild Wednesday 
Via Chartmill
Wall Street Cheers J&J’s Outlook: Morgan Stanley, Stifel Raise Targets After Q2 Beat and Guidance Lift
Analysts highlighted momentum in oncology and MedTech, with Wells Fargo calling the second-half growth acceleration “achievable” and Morgan Stanley noting visibility risks from drug pricing and tariff... 
Via Stocktwits
Topics Government World Trade
Rigetti Computing, Netflix, Johnson & Johnson, United Airlines And ASML: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78. 
Via Benzinga
Topics Stocks
3 Top Dividend Stocks Yielding More Than 3% That You Shouldn't Hesitate to Buy Right Now
Via The Motley Fool
JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now
Johnson & Johnson is back in rally mode after years of post-pandemic normalization and the impact of repositioning, set up to sustain higher prices for years. 
Via MarketBeat
Johnson & Johnson Lifts 2025 Outlook
Via The Motley Fool
Topics Intellectual Property
Why Johnson & Johnson Rallied Today
Via The Motley Fool
Topics World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.